EMA Committee Recommends Yuviwel Approval for Children With Achondroplasia
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended granting marketing authorization for Ascendis Pharma’s Yuviwel treatment for children with achondroplasia.